The Broad Institute Patents

Patent portfolio assigned to The Broad Institute (verified via public assignee records). Non-profit biomedical/genomics research institute of MIT and Harvard, not a startup/company. Holds foundational CRISPR-Cas9 patents (assignee 'The Broad Institute Inc.'). 'Competitors' not applicable; listed entries are research/funding collaborators, not paying customers.